CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

56.37  -1.55 (-2.68%)

Fundamental Rating

5

Taking everything into account, CCJ scores 5 out of 10 in our fundamental rating. CCJ was compared to 204 industry peers in the Oil, Gas & Consumable Fuels industry. CCJ has an average financial health and profitability rating. CCJ is valied quite expensively at the moment, while it does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year CCJ was profitable.
In the past year CCJ had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CCJ reported negative net income in multiple years.
Each year in the past 5 years CCJ had a positive operating cash flow.

1.2 Ratios

CCJ has a Return On Assets of 2.74%. This is in the lower half of the industry: CCJ underperforms 69.61% of its industry peers.
CCJ's Return On Equity of 4.15% is on the low side compared to the rest of the industry. CCJ is outperformed by 72.06% of its industry peers.
The Return On Invested Capital of CCJ (3.19%) is worse than 74.02% of its industry peers.
Industry RankSector Rank
ROA 2.74%
ROE 4.15%
ROIC 3.19%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 9.70%, CCJ perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
CCJ's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 14.48%, CCJ perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
CCJ's Operating Margin has improved in the last couple of years.
The Gross Margin of CCJ (24.39%) is worse than 64.71% of its industry peers.
CCJ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.48%
PM (TTM) 9.7%
GM 24.39%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%

6

2. Health

2.1 Basic Checks

CCJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CCJ has more shares outstanding
The number of shares outstanding for CCJ has been increased compared to 5 years ago.
CCJ has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 7.56 indicates that CCJ is not in any danger for bankruptcy at the moment.
CCJ has a Altman-Z score of 7.56. This is amongst the best in the industry. CCJ outperforms 92.16% of its industry peers.
CCJ has a debt to FCF ratio of 2.62. This is a good value and a sign of high solvency as CCJ would need 2.62 years to pay back of all of its debts.
CCJ has a Debt to FCF ratio of 2.62. This is in the better half of the industry: CCJ outperforms 72.06% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that CCJ is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, CCJ is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.62
Altman-Z 7.56
ROIC/WACC0.43
WACC7.37%

2.3 Liquidity

A Current Ratio of 3.22 indicates that CCJ has no problem at all paying its short term obligations.
CCJ's Current ratio of 3.22 is amongst the best of the industry. CCJ outperforms 81.37% of its industry peers.
CCJ has a Quick Ratio of 1.48. This is a normal value and indicates that CCJ is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.48, CCJ is doing good in the industry, outperforming 67.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.48

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 110.53% over the past year.
The Earnings Per Share has been growing slightly by 7.91% on average over the past years.
CCJ shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.36%.
The Revenue has been growing slightly by 4.35% on average over the past years.
EPS 1Y (TTM)110.53%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%1500%
Revenue 1Y (TTM)27.36%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%24.07%

3.2 Future

CCJ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.74% yearly.
CCJ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.44% yearly.
EPS Next Y13.15%
EPS Next 2Y41.72%
EPS Next 3Y41.41%
EPS Next 5Y28.74%
Revenue Next Year20.18%
Revenue Next 2Y13.48%
Revenue Next 3Y10.66%
Revenue Next 5Y5.44%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 97.19 indicates a quite expensive valuation of CCJ.
CCJ's Price/Earnings ratio is a bit more expensive when compared to the industry. CCJ is more expensive than 77.45% of the companies in the same industry.
When comparing the Price/Earnings ratio of CCJ to the average of the S&P500 Index (31.46), we can say CCJ is valued expensively.
With a Price/Forward Earnings ratio of 49.10, CCJ can be considered very expensive at the moment.
CCJ's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CCJ is more expensive than 73.53% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCJ to the average of the S&P500 Index (22.63), we can say CCJ is valued expensively.
Industry RankSector Rank
PE 97.19
Fwd PE 49.1

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued a bit more expensive than the industry average as 79.41% of the companies are valued more cheaply.
CCJ's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CCJ is more expensive than 64.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 63.29
EV/EBITDA 60.69

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CCJ's earnings are expected to grow with 41.41% in the coming years.
PEG (NY)7.39
PEG (5Y)12.29
EPS Next 2Y41.72%
EPS Next 3Y41.41%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.15%, CCJ is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.41, CCJ is paying slightly less dividend.
With a Dividend Yield of 0.15, CCJ pays less dividend than the S&P500 average, which is at 2.18.
Industry RankSector Rank
Dividend Yield 0.15%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has been paying a dividend for at least 10 years, so it has a reliable track record.
CCJ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-7.75%
Div Incr Years0
Div Non Decr Years5

5.3 Sustainability

CCJ pays out 20.25% of its income as dividend. This is a sustainable payout ratio.
DP20.25%
EPS Next 2Y41.72%
EPS Next 3Y41.41%

CAMECO CORP

NYSE:CCJ (10/22/2024, 1:28:03 PM)

56.37

-1.55 (-2.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap24.53B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.15%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 97.19
Fwd PE 49.1
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)7.39
PEG (5Y)12.29
Profitability
Industry RankSector Rank
ROA 2.74%
ROE 4.15%
ROCE
ROIC
ROICexc
ROICexgc
OM 14.48%
PM (TTM) 9.7%
GM 24.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.22
Quick Ratio 1.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)110.53%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y13.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.36%
Revenue growth 3Y12.86%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y